Hogdin; Katharina
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hogdin; Katharina.The latest application filed is for "nmda antagonist prodrugs".
- Hogdin; Katharina - Knivsta SE
- Hogdin; Katharina - Macclesfield Cheshire
- Hogdin; Katharina - Sodertalje SE
| Patent | Date |
|---|---|
| Nmda Antagonist Prodrugs App 20210040039 - Nordvall; Gunnar ; et al. | 2021-02-11 |
| NMDA antagonist prodrugs Grant 10,815,199 - Nordvall , et al. October 27, 2 | 2020-10-27 |
| Nmda Antagonist Prodrugs App 20190152914 - Nordvall; Gunnar ; et al. | 2019-05-23 |
| Bis(sulfonamide) derivatives and their use as mPGES inhibitors Grant 10,227,296 - Soderman , et al. | 2019-03-12 |
| NMDA antagonist prodrugs Grant 10,207,994 - Nordvall , et al. Feb | 2019-02-19 |
| Bis(sulfonamide) derivatives and their use as mPGES inhibitors Grant 10,081,614 - Soderman , et al. September 25, 2 | 2018-09-25 |
| Nmda Antagonist Prodrugs App 20180037550 - Nordvall; Gunnar ; et al. | 2018-02-08 |
| Bis(sulfonamide) Derivatives And Their Use As Mpges Inhibitors App 20180002278 - SODERMAN; Peter ; et al. | 2018-01-04 |
| NMDA antagonist prodrugs Grant 9,822,075 - Nordvall , et al. November 21, 2 | 2017-11-21 |
| Bis(sulfonamide) Derivatives And Their Use As Mpges Inhibitors App 20170313672 - SODERMAN; Peter ; et al. | 2017-11-02 |
| Nmda Antagonist Prodrugs App 20160280647 - Nordvall; Gunnar ; et al. | 2016-09-29 |
| Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia App 20090233930 - Berg; Stefan ; et al. | 2009-09-17 |
| New Compounds 835 App 20090233943 - Burrows; Jeremy Nicholas ; et al. | 2009-09-17 |
| Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related Pathologies App 20090023762 - Berg; Stefan ; et al. | 2009-01-22 |
| Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia App 20080293718 - Berg; Stefan ; et al. | 2008-11-27 |
| New Compounds 835 App 20080287460 - Burrows; Jeremy Nicholas ; et al. | 2008-11-20 |
| New Compounds 320 App 20080214577 - Berg; Stefan ; et al. | 2008-09-04 |
| New Compounds 318 App 20080058349 - Berg; Stefan ; et al. | 2008-03-06 |
| New Compounds 317 App 20080051420 - Berg; Stefan ; et al. | 2008-02-28 |
| New Compounds 319 App 20070299087 - Berg; Stefan ; et al. | 2007-12-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 